None

None

None

None

None

None

None

403 trial & test1

  You must not have scleroderma, pulmonary hypertension, diseases with similarities to scleroderma (including myositis, lupus, Sjogren’s syndrome, or rheumatoid arthritis), or other conditions that affect your immune system.

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus (APATURA)

This is a multinational, randomized, placebo-controlled, parallel treatment, Phase 2, double-blind, 2 arm study evaluating the efficacy and safety of SAR441344 in comparison with placebo in the treatment of participants aged 18 to 70 years with active Systemic Lupus Erythematosus (SLE). Study details include: Study duration: 36 weeks Treatment duration: …

Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus (LES-HYDROXY)

The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them.